MX9206790A - PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL - Google Patents

PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL

Info

Publication number: MX9206790A
Authority: MX; Mexico
Prior art keywords: gemfibrozil; development; composition; controlled release; dose form
Prior art date: 1991-11-26

Application number

MX9206790A

Other languages

Spanish (es)

Inventor

Isaac Ghebre-Sellassie

Uma Iyer

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-26

Filing date

1992-11-25

Publication date

1993-05-01

1992-11-25 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1993-05-01 Publication of MX9206790A publication Critical patent/MX9206790A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)

MX9206790A 1991-11-26 1992-11-25 PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL MX9206790A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US79837591A	1991-11-26	1991-11-26

Publications (1)

Publication Number	Publication Date
MX9206790A true MX9206790A (en)	1993-05-01

Family

ID=25173228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9206790A MX9206790A (en)	1991-11-26	1992-11-25	PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL

Country Status (5)

Country	Link
EP (1)	EP0614358A1 (en)
JP (1)	JPH07503236A (en)
CA (1)	CA2123677A1 (en)
MX (1)	MX9206790A (en)
WO (1)	WO1993010775A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE322260T1 (en) *	1996-11-15	2006-04-15	Ajinomoto Kk	NATEGLINIDE PREPARATION IN TABLET FORM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0297866A3 (en) *	1987-07-01	1989-12-13	The Boots Company PLC	Therapeutic agents
US4925676A (en) *	1989-02-02	1990-05-15	Warner-Lambert Company	Extended release gemfibrozil composition
US4927639A (en) *	1989-02-02	1990-05-22	Warner-Lambert Company	Modified release gemfibrozil composition
US4973470A (en) *	1989-06-26	1990-11-27	Warner-Lambert Company	Sustained release pharmaceutical compositions

1992
- 1992-10-15 JP JP5510096A patent/JPH07503236A/en active Pending
- 1992-10-15 CA CA002123677A patent/CA2123677A1/en not_active Abandoned
- 1992-10-15 EP EP92921783A patent/EP0614358A1/en not_active Withdrawn
- 1992-10-15 WO PCT/US1992/008782 patent/WO1993010775A1/en not_active Application Discontinuation
- 1992-11-25 MX MX9206790A patent/MX9206790A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH07503236A (en)	1995-04-06
CA2123677A1 (en)	1993-06-10
WO1993010775A1 (en)	1993-06-10
EP0614358A1 (en)	1994-09-14

Similar Documents

Publication	Publication Date	Title
NO941719L (en)	1994-11-11	Pharmaceutical preparation with controlled release effect
FI940787L (en)	1994-02-18	Dosage form for administering the drug over a short period of time
NO20053106L (en)	1995-04-10	Oral, extended-release analgesic dosage form.
AR230186A1 (en)	1984-03-01	METHOD FOR THE TREATMENT OF A COMPOSITION INCLUDING FACTOR VIII
MX9204268A (en)	1994-03-31	A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
NO912607L (en)	1992-01-06	FIXED, ORAL, PHARMACEUTICAL DOSAGE FORM WITH PROGRAMMED RELEASE
MX161165A (en)	1990-08-09	PROCEDURE FOR PREPARING A PROLONGED RELEASE PHARMACEUTICAL COMPOSITION
FR2514642B1 (en)	1987-09-11	DELAYED RELEASE PHARMACEUTICAL COMPOSITIONS
IT8867302A0 (en)	1988-04-05	DOSAGE FORM FOR CONTINUOUS RELEASE OF SIMILAR PHARMACEUTICAL SUBSTANCES
BR1100658A (en)	1999-08-31	Heterocyclic compound, pharmaceutical composition in unit dosage form, and process for the preparation of a heterocyclic compound
BE883779A (en)	1980-10-01	SPREAD RELEASE THERAPEUTIC COMPOSITIONS
BR9203769A (en)	1993-04-20	GRANULAR DETERGENT COMPOSITION AND PROCESS FOR THE PREPARATION OF THE SAME
ES508185A0 (en)	1983-08-01	A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION IN THE FORM OF A MITARIC DOSE.
AT4589U3 (en)	2002-04-25	OXYCODON COMPOSITION WITH CONTROLLED RELEASE
MX9204154A (en)	1993-05-01	PROCEDURE FOR THE PRODUCTION OF A DETERGENT COMPOSITION CONTAINING ALKYLSULPHATE PARTICLES AND BASE GRANULES.
NO153396C (en)	1986-03-12	ANALOGUE PROCEDURE FOR THE PREPARATION OF A PHARMACOLOGICALLY ACCEPTABLE POLYMARY AGENT THAT CAN RELEASE A THERAPEUTIC EFFECTIVE COMPOUND.
ES523463A0 (en)	1984-10-01	A PROCEDURE FOR PREPARING A SLOW RELEASE PERFUME COMPOSITION
PT90104A (en)	1989-11-10	A process for the preparation of a solid, rapidly disintegrating, dosage form containing diclofenac
AR008176A1 (en)	1999-12-09	ORAL DOSAGE FORM OF CONTROLLED RELEASE AND USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES
NO993627D0 (en)	1999-07-26	Use of a compound for the manufacture of a medicament
MX9206790A (en)	1993-05-01	PROCESS AND COMPOSITION FOR THE DEVELOPMENT OF A CONTROLLED RELEASE DOSE FORM OF GEMFIBROZIL
ES538606A0 (en)	1986-02-01	A PROCEDURE FOR PREPARING A SELECTED ANTIBIOTIC SUBSTANCE FROM THE ANTIBIOTIC L 17054 AND ITS SALTS BY ADDITION OF PHARMACEUTICALLY ACCEPTABLE ACIDS
ES551440A0 (en)	1988-05-16	PROCEDURE FOR OBTAINING A COATING COMPOSITION FOR SUSTAINED RELEASE DOSAGE FORMS
MX9203735A (en)	1992-09-01	AN IMPROVED DOSE FORM TO SUPPLY A DRUG OR THERAPEUTIC AGENT TO A USE ENVIRONMENT.
FI900017L (en)	1990-07-04	Method for preparing aspirin tablets with controlled release of low dose of active ingredient

Legal Events

Date	Code	Title	Description
1996-03-29	FG	Grant or registration
2014-08-29	MM	Annulment or lapse due to non-payment of fees